Actively Recruiting
Prospective Multi-Center Study to Assess Safety and Effectiveness of the REMEDY SPECTRUM IM Spacer Nail for Treating Ankle Infections
Led by OsteoRemedies, LLC · Updated on 2026-05-19
60
Participants Needed
3
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of the REMEDY SPECTRUM IM Spacer Nail in treating infections related to the ankle. This prospective, multicenter, single-arm clinical trial focuses on adults aged 21 and older who have ankle-related infections. The study is sponsored by OsteoRemedies, LLC and is expected to last about 18 months, including a 12-month enrollment period and a 6-month follow-up. All participants will receive the REMEDY SPECTRUM IM Spacer Nail, a single-use implant made of polymethylmethacrylate reinforced with a stainless-steel core and loaded with antibiotics gentamicin and vancomycin. The nail is available in two lengths to fit different patient anatomies and is combined with surgical fixation as needed to prevent migration. The study involves surgical implantation of this device. During the study, participants will undergo pre-operative and post-operative procedures while being monitored for infection treatment success based on laboratory values and cultures over a 6-month period. Researchers will assess the resolution of infection and monitor participants for safety and effectiveness of the implant. The total participation time is approximately 18 months from enrollment through follow-up.
CONDITIONS
Brief Title
Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections
Research Team
C
Crystal Djaba
J
Jacob Schafer
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here